secwatch.observer — SEC 8-K summary
======================================

Issuer:     Turn Therapeutics Inc. (TTRX)
CIK:        0002023016
Form:       8-K
Filed at:   2025-11-04T23:59:59+00:00
Accession:  0001213900-25-106265
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Turn Therapeutics Appoints Andrew Scott as VP of Corporate Communications
-------------------------------------------------------------------------

- Andrew Scott appointed VP of Corporate Communications effective November 4, 2025.
- Scott will oversee IR, capital markets strategy, and licensing partnerships.
- He joins from ThinkEquity LLC, where he was Managing Director of Investment Banking.
- Scott has helped raise approximately $3 billion across life-sciences transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2023016/000121390025106265/0001213900-25-106265-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2023016/000121390025106265/ea0264083-8k_turn.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-106265

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer